Terrence Francis Blaschke, MD
Internal Medicine · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Blaschke’s office at (650) 725-4632 to ask if they take your plan before you enroll.
California Medical Board record
Licence G22733 · Cancelled
Licence status: Cancelled · since 1972 · Columbia University College of Physicians and Surgeons.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| F. Hoffmann-La Roche AG · Clinical and Epidemiological Correlates of Treatment Change in Patients With Nmosd Insights From the Circles Cohort · 2022 | This clinician | $2,579 |
| F. Hoffmann-La Roche AG · Disease Phenotype Correlates With Treatment Change in Nmosd Patients of the Circles Cohort · 2021 | This clinician | $2,004 |
| F. Hoffmann-La Roche AG · Correlates of Rituximab Discontinuation in Patients With Nmosd A Circles Cohort Analysis · 2021 | This clinician | $1,854 |
| F. Hoffmann-La Roche AG · Novel Disability Assessment of Neuromyelitis Optica Spectrum Disorder Derived From the Circles Experience · 2021 | This clinician | $1,815 |
| F. Hoffmann-La Roche AG · Novel Assessment of Disability Vs Cognition and Pain in Neuromyelitis Optica Spectrum Disorder A Circles Cohort Study · 2021 | This clinician | $1,815 |
| F. Hoffmann-La Roche AG · Assessment of Disability and Disease Burden in Neuromyelitis Optica Spectrum Disorder: Analysis of the Circles Cohort · 2024 | This clinician | $1,505 |
| F. Hoffmann-La Roche AG · Demographics and Relapse Profile Correlates With Treatment Change in Neuromyelitis Optica Spectrum Disorder Nmosd Patients Analysis of the Circles Study · 2021 | This clinician | $1,100 |
| F. Hoffmann-La Roche AG · Demographic and Relapse Correlates of Treatment Change in Nmosd Patients Analysis of the Circles Study · 2021 | This clinician | $1,083 |
| F. Hoffmann-La Roche AG · Relapse Profile Correlates With Treatment Change in Nmosd Patients of the Circles Cohort · 2021 | This clinician | $1,061 |
| F. Hoffmann-La Roche AG · Multinomial Modeling Reveals Insights Into Disability in Nmosd A Circles Cohort Analysis · 2021 | This clinician | $598 |
| F. Hoffmann-La Roche AG · Multinomial Modeling Reveals Insights Into Disability in Nmosd A Circles Cohort Analysis Poster · 2021 | This clinician | $588 |
| F. Hoffmann-La Roche AG · Novel Assessment of Disability Vs Cognition and Pain in Neuromyelitis Optica Spectrum Disorder A Circles Cohort Study · 2022 | This clinician | $499 |
Professional record
- NPI
- 1003911272
- Licence
- CA G22733California G22733: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 855 Allardice Way, Stanford, CA, 94305
- NPI first listed
- 2006-09-13
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.